Research and Markets: Diagnoptics Technologies B.V. - Product Pipeline Analysis
DUBLIN--(BUSINESS WIRE)--Oct 16, 2012--Research and Markets ( http://www.researchandmarkets.com/research/mlpxbc/diagnoptics ) has announced the addition of GlobalData's new company profile "Diagnoptics Technologies B.V. - Product Pipeline Analysis" to their offering.
Diagnoptics Technologies B.V. (Diagnoptics) is a medical device company. It carries out the design and development of medical devices that enable non-invasive assessment of cardiovascular risk and risk of diabetes. The major products of the company include Diab-spot and AGE Reader. Diab-spot is a non-invasive test to identify people at risk for diabetes or pre-diabetes. The AGE Reader provides an immediate cardiovascular risk prediction in major chronic diseases such as diabetes, renal failure and cardiovascular disease. Diagnoptics develop the products based on its expartize in detecting fluorescence of Advanced Glycation Endproducts (AGEs). The company's products are CE marked and is available across Europe and Asia. Diagnoptics is headquartered in Groningen, the Netherlands.
This report is a source for data, analysis and actionable intelligence on the Diagnoptics Technologies B.V. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
For more information visit http://www.researchandmarkets.com/research/mlpxbc/diagnoptics Source: GlobalDataCONTACT: Research and Markets Laura Wood, Senior Manager.
firstname.lastname@example.org U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector:Healthcare KEYWORD: INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS OTHER HEALTH DIABETES SOURCE: Research and Markets Copyright Business Wire 2012 PUB: 10/16/2012 01:31 PM/DISC: 10/16/2012 01:31 PM http://www.businesswire.com/news/home/20121016006665/